Thermo Fisher Scientific
TMO
2,542 hedge funds and large institutions have $187B invested in Thermo Fisher Scientific in 2024 Q2 according to their latest regulatory filings, with 166 funds opening new positions, 1,061 increasing their positions, 924 reducing their positions, and 117 closing their positions.
42% more first-time investments, than exits
New positions opened: 166 | Existing positions closed: 117
15% more repeat investments, than reductions
Existing positions increased: 1,061 | Existing positions reduced: 924
1% more funds holding
Funds holding: 2,527 → 2,542 (+15)
0.59% more ownership
Funds ownership: 88.29% → 88.87% (+0.59%)
4% less capital invested
Capital invested by funds: $196B → $187B (-$8.13B)
11% less funds holding in top 10
Funds holding in top 10: 128 → 114 (-14)
35% less call options, than puts
Call options by funds: $955M | Put options by funds: $1.47B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$691M |
| 2 |
Swedbank
Stockholm,
Sweden
|
+$689M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$505M |
| 4 |
Vontobel Holding
Zurich,
Switzerland
|
+$382M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$347M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$2.28B |
| 2 |
TCI Fund Management
London,
United Kingdom
|
-$882M |
| 3 |
VAM
Veritas Asset Management
London,
United Kingdom
|
-$310M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$272M |
| 5 |
State Street
Boston,
Massachusetts
|
-$223M |
TMO Hedge Fund Activity: Q2 2024 in Review
2,542 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q2 2024, worth a combined $187B — down 4.2% from $196B a quarter earlier.
Buyers outnumbered sellers: 166 funds opened new TMO positions and 117 closed out — a net gain of 49 holders — while 1,061 added to existing stakes and 924 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $691M. The largest seller was Capital World Investors, cutting an estimated $2.28B.
- 2,542 institutional investors held Thermo Fisher Scientific (TMO) as of Q2 2024, up from 2,527 in Q1 2024.
- Funds reported $187B of Thermo Fisher Scientific stock for Q2 2024, down 4.2% quarter-over-quarter.
- 166 funds opened new Thermo Fisher Scientific positions in Q2 2024 and 117 closed out, a net change of +49 holders.
- The largest Thermo Fisher Scientific buyer in Q2 2024 was JP Morgan Chase, an estimated $691M added.
- The largest Thermo Fisher Scientific seller in Q2 2024 was Capital World Investors, an estimated $2.28B sold.
Based on aggregated 13F filings for Q2 2024.